Encaleret
Alternative Names: JTT-305; MK-5442Latest Information Update: 05 Nov 2023
At a glance
- Originator Japan Tobacco
- Developer Japan Tobacco; Merck & Co
- Class Amines; Benzoic acids; Calcium regulators; Ethers; Halogenated hydrocarbons; Osteoporosis therapies; Small molecules
- Mechanism of Action Calcium-sensing receptor antagonists; Osteogenesis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Osteoporosis
Most Recent Events
- 31 Oct 2011 Discontinued - Phase-II for Osteoporosis in India (PO)
- 31 Oct 2011 Discontinued - Phase-II for Osteoporosis in Japan (PO)
- 31 Oct 2011 Discontinued - Phase-II for Osteoporosis in USA (PO)